Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This clinical trial is studying the genetic changes in cells associated with different types of cancer in American Indian (AI) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. AI tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, AIs have been understudied and little is known about the molecular characterization of tumors arising in AIs. Undergoing genetic testing of tumors may improve cancer outcomes in AI participants and communities.

Eligibility criteria

Qualifiers

Male or female adults >= 18 years of age

Cancer patient undergoing active treatment or a cancer survivor

Self-identify as American Indian

Disqualifiers

Unable to provide informed consent

Individuals who are under 18 years of age

Prisoners

Trial design

Treatments tested in this trial

  • Biospecimen Collection
  • Communication Intervention
  • Genetic Testing
  • Survey Administration

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators

Mayo Clinic

Lead sponsor

National Cancer Institute (NCI)

Collaborator